524280 logo

Kopran Limited Stock Price

BSE:524280 Community·₹6.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

524280 Share Price Performance

₹131.65
-84.65 (-39.14%)
₹131.65
-84.65 (-39.14%)
Price ₹131.65

524280 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet average dividend payer.

3 Risks
1 Reward

Kopran Limited Key Details

₹5.9b

Revenue

₹3.9b

Cost of Revenue

₹2.0b

Gross Profit

₹1.9b

Other Expenses

₹176.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
3.64
34.62%
2.97%
31.3%
View Full Analysis

About 524280

Founded
1958
Employees
1024
CEO
Surendra Somani
WebsiteView website
www.kopran.com

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Recent 524280 News & Updates

Recent updates

No updates